Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Cash flows from operating activities:
Net (loss) income	$ (3,147)	$ 57,702
Adjustments to reconcile net (loss) income to net cash provided by operating activities:
Stock-based compensation	2,308	2,459
Provision for expected losses	1,805	1,285
Depreciation and amortization	13,984	13,778
Non-cash lease expense	976	1,205
Deferred income taxes	4,137	(42,098)
Other non-cash items	(643)	42
Changes in operating assets and liabilities:
Accounts receivable	(3,886)	9,509
Finance receivables	3,021	3,584
Inventory	(4,847)	(5,425)
Prepaid expenses and other assets	(2,129)	(4,386)
Accounts payable and accrued expenses	10,255	(25,999)
Operating lease liabilities	(1,167)	(1,032)
Deferred revenue	1,360	290
Net cash provided by operating activities	22,027	10,914
Cash flows from investing activities:
Capital expenditures	(10,965)	(11,917)
Acquisition of businesses, net of cash acquired	0	(11,132)
Net cash used in investing activities	(10,965)	(23,049)
Cash flows from financing activities:
Proceeds from long-term debt, net of issuance costs	0	38,995
Payments on long-term debt	(1,500)	(38,125)
Deferred consideration on the acquisition of a business	(896)	(673)
Proceeds from exercise of common stock options	1,289	53
Payment of employee taxes related to stock-based compensation	(698)	(353)
Other financing activities	0	(314)
Net cash used in financing activities	(1,805)	(417)
Effect of currency exchange rate changes on cash and cash equivalents	10	(31)
Net increase (decrease) in cash and cash equivalents	9,267	(12,583)
Cash and cash equivalents at beginning of year	51,146	58,920
Cash and cash equivalents at end of period	60,413	46,337
Supplemental disclosures of cash flow information:
Interest paid in cash	2,226	1,944
Income taxes paid in cash	$ 2,074	$ 779